MAP3K13 and cancer: Further studies revealed that depletion of MAP3K13 significantly decreased the phosphorylated-S62 form of Myc leading to its protein instability and inhibiting its transcriptional activity in MB231 and HepG2 cells with high Myc levels but had no significant effects on MCF-7 cancer cells with low Myc levels (Figure 5A and Figure 6A).